These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3036324)

  • 21. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Various characteristics of the contractile function of the heart in cardiac hypertrophy during readaptation after adaptation of the body to high-altitude hypoxia].
    Varosian MA; Martirosian MF; Tatinian NG; Petrosian VP
    Kosm Biol Aviakosm Med; 1990; 24(6):42-5. PubMed ID: 2149867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced sarcolemmal Ca2+ efflux reduces sarcoplasmic reticulum Ca2+ content and systolic Ca2+ in cardiac hypertrophy.
    Díaz ME; Graham HK; Trafford AW
    Cardiovasc Res; 2004 Jun; 62(3):538-47. PubMed ID: 15158146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.
    Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P
    J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocyte contractile dysfunction with hypertrophy and failure: relevance to cardiac surgery.
    Walker CA; Crawford FA; Spinale FG
    J Thorac Cardiovasc Surg; 2000 Feb; 119(2):388-400. PubMed ID: 10649220
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms for the transition from physiological to pathological cardiac hypertrophy.
    Oldfield CJ; Duhamel TA; Dhalla NS
    Can J Physiol Pharmacol; 2020 Feb; 98(2):74-84. PubMed ID: 31815523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.
    Yeh YH; Wakili R; Qi XY; Chartier D; Boknik P; Kääb S; Ravens U; Coutu P; Dobrev D; Nattel S
    Circ Arrhythm Electrophysiol; 2008 Jun; 1(2):93-102. PubMed ID: 19808399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.
    El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T
    Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiopathology of cardiac insufficiency. Biological factors of adaptation and disadaptation of the heart to chronic mechanical overload].
    Swynghedauw B
    Schweiz Med Wochenschr; 1995 Feb; 125(7):288-93. PubMed ID: 7878407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure.
    Babick AP; Dhalla NS
    Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophy without contractile dysfunction after reversal of pressure overload in the cat.
    Wisenbaugh T; Allen P; Cooper G; O'Connor WN; Mezaros L; Streter F; Bahinski A; Houser S; Spann JF
    Am J Physiol; 1984 Jul; 247(1 Pt 2):H146-54. PubMed ID: 6234811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of adrenergic receptor system in cardiac overload].
    Toshima H; Shida M
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1759-66. PubMed ID: 2173031
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative ultrastructural aspects of cardiac hypertrophy.
    Tomanek RJ
    Tex Rep Biol Med; 1979; 39():111-22. PubMed ID: 162243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some biochemical lesions in myocardial disease.
    Sordahl LA
    Tex Rep Biol Med; 1979; 38():121-35. PubMed ID: 161081
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemical problems in cardiac hypertrophy and chronic insufficiency].
    Swynghedauw B
    Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myocardial structure in various forms of hypertrophy. I. Myocyte hypertrophy or hyperplasia? Pathophysiological aspects and the methods of study].
    Grajek S; Paradowski S; Zajac M; Kaczmarek E
    Kardiol Pol; 1990; 33(6):375-83. PubMed ID: 2150679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of ventricular hypertrophy.
    Oparil S
    J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):57B-65B. PubMed ID: 3158693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cardiac hypertrophic responses to pathologic and physiologic loads.
    Scheuer J; Buttrick P
    Circulation; 1987 Jan; 75(1 Pt 2):I63-8. PubMed ID: 2947753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro cardiac function in early sepsis.
    McDonough KH; Burke EC; Smith LW
    J Med; 1990; 21(1-2):27-49. PubMed ID: 2212867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.